Back to contracts
Continue, Expand, and Refine Research and Development of a Hydromorphone Autoinjector
AFWERX · AFWERX TACFI · AFWERX
AI-Readiness Score
13/25
Pathway Speed
4/5
Timeline Realism
3/5
Problem Framing
3/5
AI / ML Fit
0/5
Award + Transition
3/5
Award
$1,799,613
Award ceiling
RX BANDZ, INC.
Awardee
Posted September 16, 2023
Description
The proposed TACFI effort seeks to continue, expand and refine the Phase II achievements with the goal of producing a hydromorphone auto-injector requested by the Air Force for immediately available point-of-injury care on remote and austere battlefields.
Score Rationale
The AFWERX TACFI instrument earns a strong pathway score, but this solicitation is a medical device hardware R&D effort — developing a hydromorphone autoinjector — with zero AI/ML component whatsoever; 'AI' is not even invoked, making this a 0 on fit by definition. Award ceiling of ~$1.8M with a TACFI transition pathway is modestly favorable, but the core work is pharmacological/mechanical engineering, making this solicitation entirely irrelevant for an AI-native startup.